Search
Kelun Pharmaceutical Addresses US Pharmaceutical Tariff Plan: Monitoring Developments, Minimal US Revenue Impact
2025-04-09 /
Read about 0 minute
Author：小编
In response to the United States' proposal to impose additional tariffs on pharmaceuticals, the Securities Department of Kelun Pharmaceutical has issued a statement. The company confirms that it is aware of this news and is actively monitoring the situation with relevant departments. Kelun Pharmaceutical's exports to the United States encompass both preparations and active pharmaceutical ingredients (APIs), but this segment contributes a minor portion to the company's overall revenue. Regarding the potential impact, the company notes that a clear assessment can only be made once the tariff policy is implemented, and thus, no definitive judgment can be offered at this juncture.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
